Sergey Terushkin, MD, FACS is a board-certified bariatric and weight-loss specialist leading our Mounjaro program
There is no universal winner in the Mounjaro vs Ozempic debate the right choice depends on your HbA1c, weight, budget, and heart or kidney risk, decided with a diabetes specialist, not a friends recommendation
Functional GIP receptors are present on adipocytes
Sustaining improvements after tirzepatide If tirzepatide treatment produces 15 to 20% weight loss and that weight loss is maintained through dietary habits and exercise after discontinuation, the insulin sensitization, hormonal improvement, and cycle regularity often persist
As compared to general medications that affect the entire body, peptides communicate directly with specific receptors, making them highly targeted and, in many cases, well-tolerated
With time, the success stories eased concerns